| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.034 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |